TY - JOUR
T1 - Factors associated with frequency of emergency department visits for chronic obstructive pulmonary disease exacerbation
AU - Tsai, Chu Lin
AU - Griswold, Sharon K.
AU - Clark, Sunday
AU - Camargo, Carlos A.
N1 - Funding Information:
Ackowledgments: The authors thank the EMNet investigators for their ongoing dedication to public health research, with an emphasis on the treatment and prevention of respiratory/allergy emergencies. The cohort studies were supported by an unrestricted grant from Boehringer Ingelheim (Ridgefield, Conn, USA and Burlington, Ontario, Canada). EMNet Steering Committee: Michelle P. Blanda, MD; Edwin D. Boudreaux, PhD; Carlos A. Camargo, Jr., MD (Chair); Rita K. Cydulka, MD; Theodore J. Gaeta, DO, MPH; Susan Key, RN, MS, CEN; Steven Polevoi, MD; Michael S. Radeos, MD, MPH; and Benjamin C. Sun, MD, MPP. EMNet Coordinating Center: Christina Ahn; Carlos A. Camargo, Jr., MD (Director); Sunday Clark, MPH, ScD; Lisa A. Dubois; Kate E. Delaney; Adit A. Ginde, MD; Andrea J. Pelletier, MS, MPH; Ashley F. Sullivan, MS, MPH; Chu-Lin Tsai, MD, MPH (all from the Massachusetts General Hospital, Boston, Mass, USA). Principal Investigators at the 29 Participating Sites: FC Baker III (Maine Medical Center, Portland, Maine, USA); MP Blanda (Summa Health System, Akron, Ohio, USA); ED Boudreaux (Earl K. Long Memorial Hospital, Baton Rouge, La, USA); BE Brenner (The Brooklyn Hospital Center, Brooklyn, NY, USA); CA Camargo, Jr. (Massachusetts General Hospital, Boston, Mass, USA); RK Cydulka (MetroHealth Medical Center, Cleveland, Ohio, USA); TJ Gaeta (New York Methodist Hospital, Brooklyn, NY, USA); B Goldfeder (Shands Hospital at the Univeristy of Florida, Gainesville, Fla, USA); RJ Grant (Hartford Hospital, Hartford, Conn, USA); RO Gray (Hennepin County Medical Center, Minneapolis, Minn, USA); A Guttman (Sir Mortimer B. Davis, Jewish General Hospital, Montreal, Quebec, Canada); LW Kreplick (Christ Hospital and Medical Center, Oak Lawn, Ill, USA); DS Mackey (Lethbridge Regional Hospital, Lethbridge, Alberta, Canada); A Mangione (Albert Einstein Medical Center, Philadelphia, Pa, USA); J Peters (University of Texas Health Sciences Center at San Antonio, San Antonio, Tex, USA); MS Radeos (Lincoln Medical Center, Bronx, NY); PL Rice (Brigham and Women’s Hospital, Boston, Mass, USA); BH Rowe (University of Alberta Hospital, Edmonton, Alberta, Canada); M Sama (St. Joseph Mercy Hospital, Ann Arbor, Mich, USA); D Schreiber (Stanford University Medical Center, Stanford, Calif, USA); NI Shapiro (Beth Israel Deaconess Medical Center, Boston, Mass, USA); PC Shukla (University of Texas Southwestern Medical Center, Dallas, Tex, USA); D Sinclair (Queen Elizabeth II Health Science Centre, Halifax, Nova Scotia, Canada); H Smithline (Baystate Medical Center, Springfield, Mass, USA); PE Sokolove (UC Davis Medical Center, Sacramento, Calif, USA); M Steffens (Palmetto Richland Memorial Hospital, Columbia, SC, USA); CA Terregino (Cooper Hospital/University Medical Center, Camden, NJ, USA); A Travers (Royal Alexandria Hospital, Edmonton, Alberta, Canada); and EJ Weber (UCSF Medical Center, San Francisco, Calif, USA).
PY - 2007/6
Y1 - 2007/6
N2 - BACKGROUND: Little is known about the factors associated with frequency of emergency department visits (FEDV) in chronic obstructive pulmonary disease (COPD) patients with recurrent exacerbations. OBJECTIVE: To characterize the use of emergency department (ED) services in patients with COPD exacerbation and identify factors associated with FEDV. DESIGN: A prospective, multicenter cohort study. PATIENTS: Three hundred eighty-eight patients were included. Fifty-two percent were women and the median age was 69 years (interquartile range 62-76). MEASUREMENTS: Using a standard questionnaire, consecutive ED patients with COPD exacerbation were interviewed. The number of ED visits in the previous year was retrospectively collected. RESULTS: Over the past year, this cohort reported a total of 1,090 ED visits because of COPD exacerbation. Thirteen percent of COPD patients had 6 or more ED visits, accounting for 57% of the total ED visits in the past year. Multivariate analysis showed that patients with an increased FEDV were more likely to be Hispanic (incidence rate ratio [IRR] 1.97, 95% confidence interval [CI] 1.16-3.33), to have more severe COPD as determined by previous hospitalizations (IRR 2.06, 95% CI 1.51-2.82), prior intubations (IRR 1.49, 95% CI 1.02-2.18), prior use of systemic corticosteroids (IRR 1.57, 95% CI 1.16-2.13) and methylxanthine (IRR 1.48, 95% CI 1.04-2.12), and less likely to have a primary care provider (IRR 0.51, 95% CI 0.31-0.82). CONCLUSIONS: Our results suggest that both disease and health care-related factors were associated with FEDV in COPD exacerbation. Multidisciplinary efforts through primary care provider follow-up should be assessed to test the effects on reducing the high morbidity and cost of recurrent COPD exacerbations.
AB - BACKGROUND: Little is known about the factors associated with frequency of emergency department visits (FEDV) in chronic obstructive pulmonary disease (COPD) patients with recurrent exacerbations. OBJECTIVE: To characterize the use of emergency department (ED) services in patients with COPD exacerbation and identify factors associated with FEDV. DESIGN: A prospective, multicenter cohort study. PATIENTS: Three hundred eighty-eight patients were included. Fifty-two percent were women and the median age was 69 years (interquartile range 62-76). MEASUREMENTS: Using a standard questionnaire, consecutive ED patients with COPD exacerbation were interviewed. The number of ED visits in the previous year was retrospectively collected. RESULTS: Over the past year, this cohort reported a total of 1,090 ED visits because of COPD exacerbation. Thirteen percent of COPD patients had 6 or more ED visits, accounting for 57% of the total ED visits in the past year. Multivariate analysis showed that patients with an increased FEDV were more likely to be Hispanic (incidence rate ratio [IRR] 1.97, 95% confidence interval [CI] 1.16-3.33), to have more severe COPD as determined by previous hospitalizations (IRR 2.06, 95% CI 1.51-2.82), prior intubations (IRR 1.49, 95% CI 1.02-2.18), prior use of systemic corticosteroids (IRR 1.57, 95% CI 1.16-2.13) and methylxanthine (IRR 1.48, 95% CI 1.04-2.12), and less likely to have a primary care provider (IRR 0.51, 95% CI 0.31-0.82). CONCLUSIONS: Our results suggest that both disease and health care-related factors were associated with FEDV in COPD exacerbation. Multidisciplinary efforts through primary care provider follow-up should be assessed to test the effects on reducing the high morbidity and cost of recurrent COPD exacerbations.
UR - http://www.scopus.com/inward/record.url?scp=34248531420&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34248531420&partnerID=8YFLogxK
U2 - 10.1007/s11606-007-0191-7
DO - 10.1007/s11606-007-0191-7
M3 - Article
C2 - 17410402
AN - SCOPUS:34248531420
SN - 0884-8734
VL - 22
SP - 799
EP - 804
JO - Journal of general internal medicine
JF - Journal of general internal medicine
IS - 6
ER -